As S100A8 is a well-established biomarker of inflammatory disease processes (reviewed in [86]) and these can be up-regulated in the muscular dystrophies, this protein merits further investigation as a biomarker for FSHD moving forward. Here, S100A8 is linked to facioscapulohumeral muscular dystrophy.